Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Latigo Biotherapeutics, Inc. is seeking a Senior Medical Director, Medical Affairs to lead strategic Medical Affairs activities for a clinical-stage, non-opioid acute pain program.
The role reports to the Vice President, Medical Affairs and requires strong scientific leadership across clinical development, regulatory, and commercial interfaces. The candidate will drive scientific communications, external expert engagement, and evidence-generation initiatives, helping shape launch readiness and
Job Title: Senior Medical Director, Medical Affairs
Position Type: Full Time
Location: Thousand Oaks, CA or San Francisco Bay Area
Latigo Biotherapeutics, Inc. is a biotechnology company focused on discovering and developing the next generation of non-opioid medicines for pain and pain-related syndromes. Our mission is the development of novel therapies that transform the lives of patients. The company is headquartered in Thousand Oaks, CA. At Latigo, we value science, patient-focus, and innovation.
Latigo is seeking an exceptionally talented and experienced Senior Medical Director, Medical Affairs to lead Medical Affairs strategy predominantly for our clinical-stage, non-opioid acute pain program. This individual will provide medical and scientific leadership as the program advances through late-stage clinical development and toward potential commercialization.
This role will drive development and execution of the acute pain Medical Affairs strategy, including scientific communications, external expert engagement, evidence generation, and launch readiness. A successful candidate will bring strong scientific and clinical acumen, strategic thinking, a collaborative nature, and the agility to work effectively across Clinical Development, Regulatory, Commercial, Government Affairs and other functions. This is a high-profile leadership role that will report directly to the Vice President, Medical Affairs.
Candidates should be willing to travel approximately 30-40% for internal meetings, congresses and external scientific engagements.